09:33:33 EDT Mon 20 Sep 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Nervgen Pharma Corp
Symbol NGEN
Shares Issued 40,656,328
Close 2021-09-14 C$ 2.22
Recent Sedar Documents

Nervgen Pharma grants options to buy 550,000 shares

2021-09-14 19:32 ET - News Release

Mr. Huitt Tracey reports

NERVGEN PHARMA GRANTS STOCK OPTIONS

Nervgen Pharma Corp. has granted 550,000 incentive stock options to directors, exercisable at a price of $2.10 per share for a period of five years, with vesting that is either time or performance based. All options have been granted in accordance with the policies of the TSX Venture Exchange and the conditions of the company's stock option plan.

About Nervgen Pharma Corp.

Nervgen is restoring life's potential by creating innovative solutions for the treatment of nervous system injury due to trauma or disease as a result of underlying inflammation and/or neurodegeneration. The company is initially developing drugs for the treatment of multiple sclerosis, spinal cord injury and Alzheimer's disease.

© 2021 Canjex Publishing Ltd. All rights reserved.